Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy
- 15 January 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (2), 342-346
- https://doi.org/10.1158/1078-0432.ccr-07-4790
Abstract
The identification of intracellular signaling cascades important for the growth and survival of cancer cells has led to the development of targeted cancer therapeutics aimed at blocking these signals. The mitogen-activated protein kinase (MAPK) pathway has a well-defined role in cancer biology and has been an important target in the development of targeted therapies. Recently, several small-molecule inhibitors of MAPK/extracellular signal–regulated kinase kinase (MEK), a key intermediary of MAPK signaling, have been developed and are currently being tested in clinical trials. Herein, we review the MAPK pathway, the development of small-molecule MEK inhibitors, and the results obtained to date with MEK inhibitors in human cancer trials.Keywords
This publication has 37 references indexed in Scilit:
- Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinomaMolecular Cancer Therapeutics, 2007
- Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma ModelsCancer Research, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human HeterotransplantsCancer Research, 2005
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- Ras GTPases: integrins' friends or foes?Nature Reviews Molecular Cell Biology, 2003
- Lysophosphatidic Acid Promotes Survival and Differentiation of Rat Schwann CellsJournal of Biological Chemistry, 2003
- Identification of the Anti-proliferative Protein Tob as a MAPK SubstrateJournal of Biological Chemistry, 2002
- New aspects of integrin signaling in cancerSeminars in Cancer Biology, 2000
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995